26 października 2017

THE DECISION-MAKING PRACTICE OF PUBLIC HEALTH AUTHORITIES IN POLAND ON REIMBURSEMENT OF ORPHAN DRUGS. ISPOR 2017 GLASGOW

more

26 października 2017

ECONOMIC EVALUATION AND COST-EFFECTIVENESS THRESHOLD IN PRACTICE OF DECISION-MAKING ON ORPHAN DRUG REIMBURSEMENT IN POLAND. ISPOR 2017 GLASGOW

more

26 października 2017

REGULATORY & REIMBURSEMENT DECISIONS DATABASE FOR INNOVATIVE DRUGS TO IMPROVE COSTINTENCY OF DECISION-MAKING. ISPOR 2017 GLASGOW

more

26 października 2017

METHODOLOGY TO ASSESS PRICING AND REIMBURESMENT POTENTIAL IN CENTRAL AND EASTERN EUROPEAN COUNTRIES. ISPOR 2017 GLASGOW

more

26 października 2017

FACTORS INFLUENCING INNOVATIVE DRUG REIMBURSEMENT IN POLAND. ISPOR 2017 GLASGOW

more

26 października 2017

PROBABILISTIC SENSITIVITY ANALYSIS AND ITS ROLE IN ASSESSMENT OF PROFITABILITY. ISPOR 2017 GLASGOW

more

26 października 2017

REPORTING QUALITY & TRANSPARENCY OF PUBLISHED NETWORK META-ANALYSIS. ISPOR 2017 GLASGOW

more